Clinical Trial Update: Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent laryngeal cancer has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Cancer

Drugs mentioned

• Cryosurgery
• Natural Killer (NK) cell immunotherapy (NK cell immunotherapy)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Recurrent Laryngeal Cancer | Phase 1, Phase 2 | Status: COMPLETED